Contrast-medium administration for prostate MRI can be abandoned: no(t so simple)!

Eur Radiol. 2023 Dec;33(12):8415-8416. doi: 10.1007/s00330-023-09767-x. Epub 2023 Jul 12.

Author

Olivier Rouvière^{1

2

3

4}

Affiliations

¹ Hospices Civils de Lyon, Department of Urinary and Vascular Imaging, Hôpital Edouard Herriot, Lyon, France. olivier.rouviere@netcourrier.com.
² Université de Lyon, Lyon, France. olivier.rouviere@netcourrier.com.
³ Université Lyon 1, faculté de médecine Lyon Est, Lyon, France. olivier.rouviere@netcourrier.com.
⁴ INSERM U 1032, Lyon, France. olivier.rouviere@netcourrier.com.

PMID: 37436510
DOI: 10.1007/s00330-023-09767-x

No abstract available

Publication types

Editorial

MeSH terms

Contrast Media / pharmacology
Humans
Magnetic Resonance Imaging
Male
Prostate* / diagnostic imaging
Prostatic Neoplasms* / diagnostic imaging

Substances

Contrast Media